| Date Filed | Type | Description |
| 04/03/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/21/2023 |
F-6
| Form F-6 - Registration of American Depository Receipt shares, not immediately effective: |
| 01/26/2023 |
4
| ROCHE HOLDING LTD (10% Owner) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Sold 75,000 shares
@ $1.89, valued at
$141.8k
|
|
| 11/04/2021 |
4
| ROCHE HOLDING LTD (10% Owner) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Converted 2,495,385 shares
@ $0
Converted 318,140 shares
@ $0
Converted 2,495,385 preferred shares
@ $0
Converted 318,140 preferred shares
@ $0 |
|
| 10/28/2021 |
3
| ROCHE HOLDING LTD (10% Owner) has filed a Form 3 on Entrada Therapeutics, Inc. |
| 10/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/23/2020 |
4
| ROCHE HOLDING LTD (10% Owner) has filed a Form 4 on Pandion Therapeutics, Inc.|
Txns:
| Converted 3,049,973 shares
@ $0
Bought 36,111 shares
@ $18, valued at
$650k
Converted 13,138,905 preferred shares
@ $0
Converted 2,414,098 preferred shares
@ $0 |
|
| 07/16/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/18/2019 |
3
| ROCHE HOLDINGS INC (10% Owner) has filed a Form 3 on Spark Therapeutics, Inc. |
| 03/20/2019 |
SC 13D/A
| ROCHE HOLDING LTD reports a 16.5% stake in Senseonics Holdings, Inc. |
| 08/02/2018 |
4
| ROCHE HOLDINGS INC (10% Owner) has filed a Form 4 on Foundation Medicine, Inc.|
Txns:
| Bought 13,877,949 shares
@ $137, valued at
$1901.3M
Bought 2,343,078 shares
@ $137, valued at
$321M
|
|
| 07/31/2018 |
SC 13D/A
| ROCHE HOLDING LTD reports a 100% stake in Foundation Medicine, Inc. |
| 07/23/2018 |
4
| ROCHE HOLDING LTD (10% Owner) has filed a Form 4 on Allakos Inc.|
Txns:
| Converted 4,610,723 shares
@ $0
Converted 4,108,091 options to buy
@ $0
Converted 502,632 options to buy
@ $0 |
|
| 07/18/2018 |
3
| ROCHE HOLDING LTD (10% Owner) has filed a Form 3 on Allakos Inc. |
| 06/19/2018 |
SC 13D/A
| ROCHE HOLDING LTD reports a 56.6% stake in Foundation Medicine, Inc. |
| 01/02/2018 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 07/05/2017 |
4
| ROCHE HOLDING LTD (10% Owner) has filed a Form 4 on AILERON THERAPEUTICS INC|
Txns:
| Converted 579,093 shares
@ $0
Bought 119,400 shares
@ $15, valued at
$1.8M
Converted 3,390,885 preferred shares
@ $0
Converted 735,775 preferred shares
@ $0
Converted 638,194 options to buy
@ $0
Converted 989,594 preferred shares
@ $0 |
|
| 07/05/2017 |
3/A
| ROCHE HOLDING LTD (10% Owner) has filed a Form 3/A on AILERON THERAPEUTICS INC |
| 06/28/2017 |
3
| ROCHE HOLDING LTD (10% Owner) has filed a Form 3 on AILERON THERAPEUTICS INC |
| 06/09/2017 |
SC 13D
| ROCHE HOLDING LTD reports a 23.6% stake in Senseonics Holdings, Inc. |
| 06/07/2017 |
3
| ROCHE FINANCE LTD (10% Owner) has filed a Form 3 on Senseonics Holdings, Inc. |
| 02/07/2017 |
SC 13G
| Senseonics Holdings, Inc. reports a 8.5% stake in SENSEONICS HOLDINGS, INC. |
| 02/07/2017 |
SC 13G
| AveXis, Inc. reports a 5.6% stake in AVEXIS, INC. |
| 11/17/2016 |
F-6 POS
| Form F-6 POS - Post-effective amendments for immediately effective filing |
| 03/17/2016 |
3
| ROCHE FINANCE LTD (10% Owner) has filed a Form 3 on Senseonics Holdings, Inc. |
| 04/09/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/15/2013 |
SC 13G/A
| ROCHE HOLDING LTD reports a 0% stake in § 240. Arrowhead Research Corporation |
| 04/12/2012 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material |
| 04/11/2012 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material |
| 04/06/2012 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material |
| 04/04/2012 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material |
| 03/30/2012 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material |
| 03/29/2012 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material |
| 03/20/2012 |
DEFC14A
| Form DEFC14A - Definitive proxy statement, contested solicitations: |
|